Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction - A post hoc analysis of the cel-02 phase IIa study.
Am Heart J. 2023 Aug;262:75-82. doi: 10.1016/j.ahj.2023.04.009. Epub 2023 Apr 22.
Am Heart J. 2023.
PMID: 37088164
Free PMC article.
Clinical Trial.
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
Bor WL, de Veer AJW, Olie RH, Rikken SAOF, Chan Pin Yin DRPP, Herrman JPR, Vrolix M, Meuwissen M, Vandendriessche T, van Mieghem C, Magro M, Bennaghmouch N, Hermanides R, Adriaenssens T, Dewilde WJM, Ten Berg JM.
Bor WL, et al. Among authors: rikken saof.
EuroIntervention. 2022 Jul 22;18(4):e303-e313. doi: 10.4244/EIJ-D-21-00703.
EuroIntervention. 2022.
PMID: 35370126
Free PMC article.
Item in Clipboard
Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.
Rikken SAOF, Selvarajah A, Hermanides RS, Coller BS, Gibson CM, Granger CB, Lapostolle F, Postma S, van de Wetering H, van Vliet RCW, Montalescot G, Ten Berg JM, van 't Hof AWJ; CELEBRATE investigators.
Rikken SAOF, et al.
Am Heart J. 2023 Apr;258:119-128. doi: 10.1016/j.ahj.2022.12.015. Epub 2022 Dec 31.
Am Heart J. 2023.
PMID: 36592878
Free article.
Clinical Trial.
Item in Clipboard
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
Rikken SAOF, van 't Hof AWJ, Ten Berg JM, Kereiakes DJ, Coller BS.
Rikken SAOF, et al.
J Am Heart Assoc. 2023 Dec 19;12(24):e031855. doi: 10.1161/JAHA.123.031855. Epub 2023 Dec 8.
J Am Heart Assoc. 2023.
PMID: 38063187
Free PMC article.
Review.
Item in Clipboard
Optimizing Antiplatelet Pretreatment in STEMI: The Crucial Role of Timing and Agent Selection.
Rikken SAOF, Ten Berg JM, van 't Hof AWJ.
Rikken SAOF, et al.
JACC Cardiovasc Interv. 2024 Mar 25;17(6):820-821. doi: 10.1016/j.jcin.2024.01.302.
JACC Cardiovasc Interv. 2024.
PMID: 38538177
No abstract available.
Item in Clipboard
Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
Rikken SAOF, Storey RF, Andreotti F, Clemmensen P, Ten Berg JM.
Rikken SAOF, et al.
Thromb Haemost. 2023 Feb;123(2):150-158. doi: 10.1055/s-0042-1753479. Epub 2022 Sep 8.
Thromb Haemost. 2023.
PMID: 36075236
Free article.
Item in Clipboard
Cite
Cite